Status:

COMPLETED

Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?

Lead Sponsor:

Kaiser Permanente

Collaborating Sponsors:

National Institute on Aging (NIA)

Brown University

Conditions:

Dementia

Med: Dementia

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

The primary objective is to assess the effectiveness of training a clinician to be a 'value champion' within clinical settings to decrease the use of three classes of potentially inappropriate prescri...

Detailed Description

Background on Condition, Disease, or Other Primary Study Focus: For people living with dementia (PLWD) the overuse of Potentially Inappropriate Medications (PIMs), those for which the potential for h...

Eligibility Criteria

Inclusion

  • Inclusion Criteria - clinician practices:
  • Clinical practices with 3 or more primary care providers (defined as a primary care physician (specialty code of 08 or 11), nurse practitioner (specialty code = 50) or physician's assistant (specialty code = 97), and
  • Clinical practices with clinical encounters with 10 or more Medicare beneficiaries with Alzheimer's or Alzheimer's related dementia in the base years (2019-2020).
  • Inclusion Criteria - Medicare beneficiaries:
  • Seen by a clinician at a participating practice as evidenced by one or more evaluation and management claim,
  • Continuous coverage in Medicare Parts A, B and D and no months of Part C (Medicare Advantage),
  • Two or more claims with an International Statistical Classification of Diseases (ICD-10) diagnosis for Alzheimer's or Alzheimer's related dementia 30 days apart or 1 inpatient stay with a principal diagnosis of Alzheimer's.
  • Exclusion Criteria- Medicare beneficiaries:
  • Medicare beneficiaries with a diagnosis of metastatic cancer or
  • Medicare beneficiaries enrolled in hospice any time in the 6 months before the start of the intervention

Exclusion

    Key Trial Info

    Start Date :

    August 30 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 31 2023

    Estimated Enrollment :

    3300 Patients enrolled

    Trial Details

    Trial ID

    NCT05359679

    Start Date

    August 30 2023

    End Date

    October 31 2023

    Last Update

    May 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Kaiser Permanente Washington Health Research Institute

    Seattle, Washington, United States, 98101